2003, Clinical Development, Marketing and Pharmacy

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2003

Clinical Development

Marketing

Pharmacy

Marquis Who’s Who Honors James D. McChesney, PhD, with Inclusion in Who’s Who in the World

The Pharma Data

NOVEMBER 11, 2020

McChesney developed an early reputation for academic excellence, earning an undergraduate scholarship from the Ford Motor Company Fund, and a National Science Foundation fellowship for his postgraduate study. Dr. McChesney entered the private sector in 1996 as the vice president of development at NaPro BioTherapeutics Inc.,

Organic Chemistry

Organic Chemistry Science Pharmacy Pharmaceuticals

Analysis Life Sciences Thank You FDA’s nonprescription advisors find no efficacy for phenylephrine

Agency IQ

SEPTEMBER 15, 2023

Until recently, the FDA relied on a monograph process through which firms could bring OTC drugs to market without FDA approval so long as it adhered to pre-set terms under the monograph. CHPA predicted that the removal of oral phenylephrine from the market would lead to significant burden to both consumers and the healthcare system.

Science

Science FDA Clinical Trials Pharmacy

Drug Discovery Digest

Marquis Who’s Who Honors James D. McChesney, PhD, with Inclusion in Who’s Who in the World

Analysis Life Sciences Thank You FDA’s nonprescription advisors find no efficacy for phenylephrine

Stay Connected